UniSuper Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $717K | Sell |
2,200
-300
| -12% | -$97.8K | ﹤0.01% | 583 |
|
|
2025
Q1 | $675K | Hold |
2,500
| – | – | 0.01% | 583 |
|
|
2024
Q4 | $588K | Sell |
2,500
-500
| -17% | -$118K | ﹤0.01% | 583 |
|
|
2024
Q3 | $825K | Hold |
3,000
| – | – | 0.01% | 587 |
|
|
2024
Q2 | $729K | Buy |
3,000
+1,200
| +67% | +$292K | 0.01% | 666 |
|
|
2024
Q1 | $269K | Buy |
1,800
+900
| +100% | +$135K | ﹤0.01% | 899 |
|
|
2023
Q4 | $172K | Hold |
900
| – | – | ﹤0.01% | 552 |
|
|
2023
Q3 | $159K | Hold |
900
| – | – | ﹤0.01% | 507 |
|
|
2023
Q2 | $171K | Buy |
+900
| New | +$171K | ﹤0.01% | 501 |
|